Amplitude Clinical Outcomes’ Post

Don't forget! Join us TOMORROW for a virtual panel discussion about the latest trends in specialty pharmacy outcomes measurement. Register: https://bit.ly/4bNgQLM Join report co-authors and specialty experts Drs. Jessica Mourani Doueiry, Brandon Newman, PharmD, MMHC, CSP, and Susan Trieu as they discuss: ➡️ HSSP clinical outcomes measurement trends for 2024 ➡️ Ways HSSPs are addressing social determinants of health ➡️ How to use technology for HSSP reporting and outcomes measurement ➡️ The clinical and patient impact data you need to demonstrate HSSP value ✅ Register: https://bit.ly/4bNgQLM #pharmacy #specialtypharmacy #HSSPoutcomes #webinar #hospital #healthsystem #communityhealth #healthcare #patientoutcomes

📊 Evidence Matters! 💡 Join us and our partners Asserta Global Healthcare Solutions at the #EAHP Congress to discover how evidence-informed policymaking can revolutionize healthcare. Let's showcase the real impact of hospital and clinical pharmacy interventions on patient outcomes and drive value-driven decisions. Ready to shape the future with data? See you in #EAHP2024 #BORDEAUX! #EvidenceBasedPolicy #HealthcareInnovation #ValueDrivenDecisions

Council for International Organizations of Medical Sciences (CIOMS) Newsletter #June 2024 CIOMS's recent newsletter showcases significant progress, including a comprehensive report on real-world data and evidence in regulatory decision-making—an indispensable tool for regulators, healthcare payers, and industry professionals. They also unveiled a draft report on severe cutaneous adverse reactions (SCAR) to improve recognition and treatment. Additionally, CIOMS is leading initiatives to develop educational standards for health professionals in medicine development and update their glossary of ICH terms and definitions. These efforts are crucial in our global mission to elevate patient safety standards. I am proud to support CIOMS and their dedication to this vital cause. Together, we can make a significant impact on healthcare worldwide. #PatientSafety #RegulatoryAffairs #HealthcareInnovation #RealWorldEvidence #MedicalEducation #GlobalHealth #pharmout PharmOut

#Didyouknow Health Service Executive and IPHA have announced their model Clinical Trial Agreement #CTA for tripartite clinical trials Read more: https://lnkd.in/dV5_7Kqh The model Clinical Trial Agreement (“mCTA”) for tripartite clinical trials has become mandatory and is available here: https://lnkd.in/duptdNq5 The mCTA for tripartite engagements involves a commercial sponsor, a #contractresearchorganisation and a hospital(s). The objectives are to reduce delays for #hospitals, to lower the associated costs through the timely conduct of #clinicaltrials, and to improve patient outcomes. #clinicalresearch

Join our free upcoming webinar to refresh your knowledge of the latest best practice guidelines for managing gout and eczema, featuring expert presenters who will provide essential clinical insights and evidence-based recommendations for these common conditions. Enrol now: https://bit.ly/4ioZZlO #QualityUseOfMedicines #GoutManagement #EczemaCare #ClinicalGuidelines #HealthcareProfessionals #EvidenceBasedPractice #CPDEducation #AustralianGPs #Medcast #MedcastEducation

✨ How would it feel to take the stress out of PHIN reporting? Our electronic PROMS solution is built to make compliance with the CMA's Private Healthcare Market Investigation Order straightforward, practical, and efficient. Designed for private hospitals and NHS private patient units alike, Amplitude Clinical Outcomes helps ensure compliance with minimal effort on your end. We’d love to walk you through how our clients have achieved compliance in as little as 3 months. Let’s discuss how we can do the same for you. #AmplitudeOutcomes #ComplianceSolutions #PHINReporting #CMA #HealthcareEfficiency

On this #ClinicalTrialsDay, I’d like to recognize the vital role that Patient Safety and Patient Science play in improving patient lives and advancing healthcare.     Patient Safety lies at the core of our clinical trials, and we are committed to prospective and proactive safety management throughout the product lifecycle. Our unwavering focus on safety monitoring and characterizing the benefit/risk profiles of medicines underscores our responsibility to patients. The convergence of science, data, technology, and innovation will continue to move us forward and deliver for patients.    We’re actively working to enhance clinical trial diversity, ensuring that our research efforts are inclusive and reflective of the diverse populations affected by various disease states. And we are evolving by pioneering new approaches to engage with patients, trial teams, and healthcare providers.    Thanks to everyone who plays a part in clinical trials! As we shape the future to be more inclusive and strive to get medicines to patients faster, let's celebrate the progress we've made and the collaborative spirit that propels us forward. Magnus Nord, Mayur A Patel, Arshad Mujeebuddin, Alexandre Kiazand and Barbara Valastro #PatientSafety #PatientCentricity #ClinicalTrialDiversity

❗️ Diagnostic tools are essential for clinicians ❗️ I'm sure I'm not alone in being alarmed to read about measures potentially being put in place that limit access to critical diagnostic tools, such as CT scans, due to financial pressures. While managing deficits is important, we must not compromise the ability of healthcare professionals to make informed, accurate decisions that directly impact patient outcomes. The HSJ article highlights, removing these tools which are labelled as "non-essential" could have serious consequences. Diagnostic imaging plays a pivotal role in early detection, monitoring, and treatment planning. It is not just a luxury; it’s a necessity for effective clinical care. Healthcare should never be forced into a position where budget constraints overshadow patient safety. Let’s ensure clinicians have the resources they need to provide the best possible care. 🏥🔍 #Healthcare #ClinicalDecisions #PatientSafety #Diagnostics #CTScans #HealthcareFinance

I am happy to announce my completion of the NIDA Clinical Trials Network's Good Clinical Practice Certificate. This experience has been incredibly enriching, offering invaluable insights into the intricate world of clinical trials. Through this program, I have deepened my understanding of the crucial role clinical trials play in enhancing patient health and well-being. I now have a deeper appreciation for their pivotal role in advancing healthcare outcomes. #GoodClinicalPractice #NIDA #ClinicalResearch

AFMCP Speaker Q&A – Ask the Experts Your Functional Medicine Questions 💡 Got questions about the latest in functional medicine❓ AFMCP’s live Speaker Q&A sessions are here to provide answers! These sessions are designed to be interactive, offering you the opportunity to ask functional medicine experts about real-world applications of clinical tools. Whether it’s about patient care, treatment plans, or lifestyle interventions, these Q&As offer personalised advice and deeper insights to take your practice to the next level. Engage with the leaders who are shaping the future of healthcare! 🔍https://buff.ly/3NHRJPm #AFMCP #SpeakerQandA #FunctionalMedicine #PersonalisedCare #ClinicalInsights